Mucus production and chronic obstructive pulmonary disease, a possible treatment target: zooming in on N-acetylcysteine
Monaldi Archives for Chest Disease · 2025
DOI: 10.4081/monaldi.2025.3159 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Monaldi Archives for Chest Disease, 2025. Verfasst von Federico Baraldi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Respiratory Medicine, Department of Translational Medicine, University of Ferrara. Hauptthemen laut MEDLINE: Acetylcysteine, Pulmonary Disease, Chronic Obstructive, Mucus. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: COPD
Abstract (Originalsprache)
Mucus hypersecretion is a trait of chronic obstructive pulmonary disease (COPD) associated with poorer outcomes. As it may be present before airway obstruction, its early treatment may have a preventive role. This narrative review of the literature presents the role of mucus dysfunction in COPD, its pathophysiology, and the rationale for the use of N-acetylcysteine (NAC). NAC can modify mucus rheology, improving clearance and reducing damage induced MUC5AC expression. It exerts a direct and indirect (glutathione replenishment) antioxidant mechanism; it interferes with inflammatory molecular pathways, including inhibition of nuclear factor-kB activation in epithelial airway cells and reduction in the expression of cytokine tumor necrosis factor α, interleukin (IL)-6, and IL-10. Some clinical experiences suggest that the adjunctive use of NAC may reduce symptoms and improve outcomes for patients with COPD. In conclusion, NAC may be a candidate drug for the early treatment of subjects at risk of COPD development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Respiratory Medicine, Department of Translational Medicine, University of Ferrara.
- Section of Respiratory Medicine, Department of Translational Medicine, University of Ferrara; Respiratory Unit, ULSS 8 Berica, Vicenza.
- Department of Medical and Surgical Sciences, University of Foggia.
- Respiratory Unit, Integrated University Hospital of Verona.
- Department of Medical and Surgical Sciences, University of Foggia; Respiratory Medicine, Policlinico of Foggia.
- Department of Medicine, Surgery and Dentistry, University of Salerno.
ORCID-Profile: Federico Baraldi, Tommaso Bigoni, Claudio Micheletto, Giulia Scioscia, Alessandro Vatrella, Alberto Papi
Zitieren
APA
Baraldi, F., Bigoni, T., Foschino Barbaro, M. P., Micheletto, C., Scioscia, G., Vatrella, A., & Papi, A. (2025). Mucus production and chronic obstructive pulmonary disease, a possible treatment target: zooming in on N-acetylcysteine. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2025.3159
Vancouver
Baraldi F, Bigoni T, Foschino Barbaro MP, Micheletto C, Scioscia G, Vatrella A, et al. Mucus production and chronic obstructive pulmonary disease, a possible treatment target: zooming in on N-acetylcysteine. Monaldi Archives for Chest Disease. 2025. doi:10.4081/monaldi.2025.3159
BibTeX
@article{Baraldi2025,
author = {Baraldi, Federico and Bigoni, Tommaso and Foschino Barbaro, Maria Pia and Micheletto, Claudio and Scioscia, Giulia and Vatrella, Alessandro and Papi, Alberto},
title = {Mucus production and chronic obstructive pulmonary disease, a possible treatment target: zooming in on N-acetylcysteine},
journal = {Monaldi Archives for Chest Disease},
year = {2025},
doi = {10.4081/monaldi.2025.3159}
}
EUVIMED